INC Research, SAS Collaborate to Improve Clinical Trials Outcomes
INC Research and SAS are working together to improve clinical development risk management and achieve targeted product profiles through analytics. Collaborating with SAS, INC Research aims to offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency, and flexibility. The ultimate goal is to improve a customer’s ability to manage risk, control investment, and maximize ROI in clinical development.
“In an environment of growing trial complexity and shrinking R&D budgets, our biopharmaceutical customers demand innovative solutions and enhanced efficiencies in drug development,” said James Ogle, INC Research Chief Executive Officer. “By joining forces with SAS and its advanced analytics platform, INC Research aims to help customers better predict commercially successful outcomes earlier in the process to maximize development efforts.”
SAS’ advanced analytics platform will boost INC Research’s ability to optimize clinical trial designs and proactively manage operations. By gaining access to SAS software through a hosted delivery model, INC Research hopes customers will achieve more rapid and informed decisions, faster time to market, and improved cash flow.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
